Mediqventures
Mediqventures is a venture capital firm based in Douglas, Isle of Man, that focuses on investments in the life sciences sector. The firm targets both early and late-stage companies, particularly those developing therapeutic assets related to metabolic diseases, oncology, and infectious diseases. In addition to providing equity financing, Mediqventures supports its portfolio companies by connecting them with a network of drug-development professionals who offer expertise in areas such as discovery programs, finance, and preclinical development. The firm's approach combines financial backing with strategic guidance to foster the growth of innovative biotech ventures.
Causeway Therapeutics
Venture Round in 2023
Causeway Therapeutics Ltd is a clinical-stage biopharmaceutical company based in Glasgow, United Kingdom, focused on developing innovative microRNA therapies for musculoskeletal health. Founded in 2015, the company specializes in treating tendon injuries and disorders in both humans and horses. Its primary products include EquiMiR, designed to treat equine tendinopathy by mimicking natural microRNA with enhanced pharmacological properties, and TenoMiR, which aims to restore key microRNA levels to enhance tendon strength and aid recovery. By targeting the molecular mechanisms that lead to tendinopathy, Causeway Therapeutics seeks to provide effective solutions for managing pain and promoting healing in damaged tendons.
Beckley Psytech
Series A in 2020
Beckley Psytech Limited is a biotechnology company based in Oxford, United Kingdom, that develops psychedelic drugs aimed at treating psychiatric and neurological disorders. Founded in 2014, it focuses on harnessing the therapeutic potential of substances such as psilocybin to address significant mental health challenges, including depression and other debilitating neuropsychiatric conditions with considerable unmet needs. The company aims to integrate clinically validated psychedelic medicines into mainstream medical practices, offering patients innovative treatment options that differentiate from existing therapies. Through its drug pipeline, Beckley Psytech is committed to providing alternative solutions for those suffering from various mental health issues.
Causeway Therapeutics
Seed Round in 2017
Causeway Therapeutics Ltd is a clinical-stage biopharmaceutical company based in Glasgow, United Kingdom, focused on developing innovative microRNA therapies for musculoskeletal health. Founded in 2015, the company specializes in treating tendon injuries and disorders in both humans and horses. Its primary products include EquiMiR, designed to treat equine tendinopathy by mimicking natural microRNA with enhanced pharmacological properties, and TenoMiR, which aims to restore key microRNA levels to enhance tendon strength and aid recovery. By targeting the molecular mechanisms that lead to tendinopathy, Causeway Therapeutics seeks to provide effective solutions for managing pain and promoting healing in damaged tendons.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.